Cargando…

TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS

Binding of tumour necrosis factor α (TNFα) to its receptor (TNFR1) is critical for both survival and death cellular pathways. TNFα/TNFR1 signalling is complex and tightly regulated at different levels to control cell fate decisions. Previously, we identified TNFR1-d2, an exon 2-spliced transcript of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rittore, Cécile, Méchin, Déborah, Sanchez, Elodie, Marinèche, Léa, Ea, Vuthy, Soler, Stephan, Vereecke, Marion, Mallavialle, Aude, Richard, Eric, Duroux-Richard, Isabelle, Apparailly, Florence, Touitou, Isabelle, Grandemange, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893027/
https://www.ncbi.nlm.nih.gov/pubmed/33603056
http://dx.doi.org/10.1038/s41598-021-83539-9
_version_ 1783652977875091456
author Rittore, Cécile
Méchin, Déborah
Sanchez, Elodie
Marinèche, Léa
Ea, Vuthy
Soler, Stephan
Vereecke, Marion
Mallavialle, Aude
Richard, Eric
Duroux-Richard, Isabelle
Apparailly, Florence
Touitou, Isabelle
Grandemange, Sylvie
author_facet Rittore, Cécile
Méchin, Déborah
Sanchez, Elodie
Marinèche, Léa
Ea, Vuthy
Soler, Stephan
Vereecke, Marion
Mallavialle, Aude
Richard, Eric
Duroux-Richard, Isabelle
Apparailly, Florence
Touitou, Isabelle
Grandemange, Sylvie
author_sort Rittore, Cécile
collection PubMed
description Binding of tumour necrosis factor α (TNFα) to its receptor (TNFR1) is critical for both survival and death cellular pathways. TNFα/TNFR1 signalling is complex and tightly regulated at different levels to control cell fate decisions. Previously, we identified TNFR1-d2, an exon 2-spliced transcript of TNFRSF1A gene encoding TNFR1, whose splicing may be modulated by polymorphisms associated with inflammatory disorders. Here, we investigated the impact of TNFRSF1A variants involved in TNFR-associated periodic syndrome (TRAPS) on TNFR1-d2 protein expression and activity. We found that TNFR1-d2 could be translated by using an internal translation initiation codon and a de novo internal ribosome entry site (IRES), which resulted in a putative TNFR1 isoform lacking its N-terminal region. The kinetic of assembly of TNFR1-d2 clusters at the cell surface was reduced as compared with full-length TNFR1. Although co-localized with the full-length TNFR1, TNFR1-d2 neither activated nuclear factor (NF)-κB signalling, nor interfered with TNFR1-induced NF-κB activation. Translation of TNFR1-d2 carrying the severe p.(Thr79Met) pathogenic variant (also known as T50M) was initiated at the mutated codon, resulting in an elongated extracellular domain, increased speed to form preassembled clusters in absence of TNFα, and constitutive NF-κB activation. Overall, TNFR1-d2 might reflect the complexity of the TNFR1 signalling pathways and could be involved in TRAPS pathophysiology of patients carrying the p.(Thr79Met) disease-causing variant.
format Online
Article
Text
id pubmed-7893027
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78930272021-02-23 TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS Rittore, Cécile Méchin, Déborah Sanchez, Elodie Marinèche, Léa Ea, Vuthy Soler, Stephan Vereecke, Marion Mallavialle, Aude Richard, Eric Duroux-Richard, Isabelle Apparailly, Florence Touitou, Isabelle Grandemange, Sylvie Sci Rep Article Binding of tumour necrosis factor α (TNFα) to its receptor (TNFR1) is critical for both survival and death cellular pathways. TNFα/TNFR1 signalling is complex and tightly regulated at different levels to control cell fate decisions. Previously, we identified TNFR1-d2, an exon 2-spliced transcript of TNFRSF1A gene encoding TNFR1, whose splicing may be modulated by polymorphisms associated with inflammatory disorders. Here, we investigated the impact of TNFRSF1A variants involved in TNFR-associated periodic syndrome (TRAPS) on TNFR1-d2 protein expression and activity. We found that TNFR1-d2 could be translated by using an internal translation initiation codon and a de novo internal ribosome entry site (IRES), which resulted in a putative TNFR1 isoform lacking its N-terminal region. The kinetic of assembly of TNFR1-d2 clusters at the cell surface was reduced as compared with full-length TNFR1. Although co-localized with the full-length TNFR1, TNFR1-d2 neither activated nuclear factor (NF)-κB signalling, nor interfered with TNFR1-induced NF-κB activation. Translation of TNFR1-d2 carrying the severe p.(Thr79Met) pathogenic variant (also known as T50M) was initiated at the mutated codon, resulting in an elongated extracellular domain, increased speed to form preassembled clusters in absence of TNFα, and constitutive NF-κB activation. Overall, TNFR1-d2 might reflect the complexity of the TNFR1 signalling pathways and could be involved in TRAPS pathophysiology of patients carrying the p.(Thr79Met) disease-causing variant. Nature Publishing Group UK 2021-02-18 /pmc/articles/PMC7893027/ /pubmed/33603056 http://dx.doi.org/10.1038/s41598-021-83539-9 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rittore, Cécile
Méchin, Déborah
Sanchez, Elodie
Marinèche, Léa
Ea, Vuthy
Soler, Stephan
Vereecke, Marion
Mallavialle, Aude
Richard, Eric
Duroux-Richard, Isabelle
Apparailly, Florence
Touitou, Isabelle
Grandemange, Sylvie
TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_full TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_fullStr TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_full_unstemmed TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_short TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_sort tnfr1-d2 carrying the p.(thr79met) pathogenic variant is a potential novel actor of tnfα/tnfr1 signalling regulation in the pathophysiology of traps
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893027/
https://www.ncbi.nlm.nih.gov/pubmed/33603056
http://dx.doi.org/10.1038/s41598-021-83539-9
work_keys_str_mv AT rittorececile tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT mechindeborah tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT sanchezelodie tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT marinechelea tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT eavuthy tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT solerstephan tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT vereeckemarion tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT mallavialleaude tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT richarderic tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT durouxrichardisabelle tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT apparaillyflorence tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT touitouisabelle tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT grandemangesylvie tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps